Retatrutide
Chemical compound
Retatrutide
Retatrutide is an experimental drug for obesity developed by the American pharmaceutical company Eli Lilly and Company. It is a triple hormone receptor agonist on the GLP-1, GIP, and glucagon receptors.
Read on Wikipedia · Image Benff, CC BY-SA 4.0
Open boosters, collect cards and trade them. Free to play.
Play for free